Cis Bio Intl Sa Company Profile
What is the competitive landscape for CIS BIO INTL SA
CIS BIO INTL SA has two approved drugs.
Drugs and US Patents for Cis Bio Intl Sa
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cis Bio Intl Sa | NEO TECT KIT | technetium tc-99m depreotide | INJECTABLE;INJECTION | 021012-001 | Aug 3, 1999 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Cis Bio Intl Sa | ACUTECT | technetium tc-99m apcitide | INJECTABLE;INJECTION | 020887-001 | Sep 14, 1998 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Cis Bio Intl Sa
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Cis Bio Intl Sa | ACUTECT | technetium tc-99m apcitide | INJECTABLE;INJECTION | 020887-001 | Sep 14, 1998 | 5,443,815 | ⤷ Start Trial |
| Cis Bio Intl Sa | ACUTECT | technetium tc-99m apcitide | INJECTABLE;INJECTION | 020887-001 | Sep 14, 1998 | 5,645,815 | ⤷ Start Trial |
| Cis Bio Intl Sa | ACUTECT | technetium tc-99m apcitide | INJECTABLE;INJECTION | 020887-001 | Sep 14, 1998 | 5,508,020 | ⤷ Start Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.

